IMRX vs REGN: Which Stock is Better?
Side-by-side comparison of Immuneering Corp and Regeneron Pharmaceuticals Inc in 2026
IMRX
Immuneering Corp
$5.56
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | IMRX | REGN | Winner |
|---|---|---|---|
| Market Cap | $360.12M | $79.35B | REGN |
| P/E Ratio | N/A | 18.08 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | -1.0% | 0.0% | REGN |
| Gross Margin | 34907.7% | 44.6% | IMRX |
Analyze IMRX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMRX or REGN a better investment?
Comparing IMRX and REGN: Immuneering Corp has a market cap of $360.12M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMRX and REGN?
IMRX (Immuneering Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMRX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMRX or REGN?
REGN has higher revenue growth at 0.0% vs -1.0% for IMRX.
Which company is more profitable: IMRX or REGN?
Immuneering Corp (IMRX) has higher gross margins at 34907.7% compared to 44.6% for REGN.
Which is the larger company: IMRX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $360.12M for IMRX.
Should I buy IMRX or REGN in 2026?
Both IMRX and REGN have investment merit. IMRX trades at $5.56 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMRX and REGN stock?
Key differences: Market Cap ($360.12M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (34907.7% vs 44.6%).